Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth.
Ogata
A
A
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Anderson
K C
KC
D002455:Cell Division / Q000187:drug effects; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology*; D009101:Multiple Myeloma / Q000473:pathology*; D014407:Tumor Cells, Cultured
D015850:Interleukin-6